Connect your AI

SION SION Other Commercial Liabilities

Other Commercial Liabilities at other companies

Vertex PharmaceuticalsVRTX

——

Septerna, Inc.SEPN

——

BioCryst PharmaceuticalsBCRX

——

Denali Therapeutics Inc.DNLI

——

Other financials

Income statement

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

Market cap$1.86B—

Returns & leverage

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SION's other commercial liabilities?: SION (SION) reported other commercial liabilities of $6.33M in Q1 2026.
How has SION's other commercial liabilities changed year-over-year?: SION's other commercial liabilities increased by 86.7% year-over-year, from $3.39M to $6.33M.